Longeveron vs Shattuck Labs
Longeveron is the larger business, with $1.2m of revenue in fiscal 2025 against $1.0m for Shattuck Labs (1.2 times as much). Longeveron grew faster (-49.9% against -82.5%). Longeveron kept more of each dollar of sales as profit: a net margin of -1893.6% against -4880.9%. Longeveron carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | LongeveronLGVN, 2025 | Shattuck LabsSTTK, 2025 |
|---|---|---|
| Revenue | $1.2m | $1.0m |
| Revenue growth | -49.9% | -82.5% |
| Net income | −$22.7m | −$48.8m |
| Operating margin | -1942.2% | -5150.8% |
| Net margin | -1893.6% | -4880.9% |
| Return on equity | -164.7% | -60.3% |
| Free cash flow | −$18.9m | −$40.0m |
| Cash | $4.7m | $54.2m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 37 | 40 |
| Market value | $55.5m | $546m |
| Price vs our value range | — | — |
| Moat score | 19 (Weak) | 12 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 1 buys, 6 sales |